Liu, Hejun http://orcid.org/0000-0002-2412-7853
Kaku, Chengzi I. http://orcid.org/0000-0002-9854-8351
Song, Ge
Yuan, Meng http://orcid.org/0000-0001-9754-4503
Andrabi, Raiees http://orcid.org/0000-0001-8837-7520
Burton, Dennis R. http://orcid.org/0000-0001-6711-9864
Walker, Laura M.
Wilson, Ian A. http://orcid.org/0000-0002-6469-2419
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-004923)
Article History
Received: 13 February 2022
Accepted: 11 July 2022
First Online: 29 July 2022
Competing interests
: C.I.K. and L.M.W. are employees of Adimab, LLC and hold shares in Adimab, LLC. L.M.W. is an employee of Adagio Therapeutics Inc. and holds shares in Adagio Therapeutics Inc. L.M.W. is an inventor on a patent describing the ADI anti-SARS-CoV-2 antibodies. I.A.W. and D.R.B. receive research funding from Adagio. Other authors declare no competing interests.